Navigation Links
Mission Pharmacal Launches Alamo Pharma Services
Date:1/26/2012

SAN ANTONIO, Jan. 26, 2012 /PRNewswire/ -- Mission Pharmacal Company announces the recent formation of Alamo Pharma Services.  This new business unit, a wholly owned subsidiary of Mission, will provide pharmaceutical sales teams with operational and human resources (HR) support.  Alamo will be headquartered in Doylestown, Pennsylvania, expanding Mission's Northeastern United States presence, which also includes the company's Commercial Group operations and BioComp Pharma, Mission's lifecycle management and generics company.

"Alamo is an outgrowth of my grandfather, H.N. Walsdorf's, longstanding commitment to service excellence.  The organization was created to be a strategic partner for the Mission sales teams, providing best-in-class operational support," notes Neill Walsdorf Jr, president of Mission Pharmacal Company.  "Alamo enables Mission to take advantage of unique sales and marketing opportunities that will drive financial results and bottom-line success."

Initially, Alamo will focus on those sales teams representing Mission's four primary therapeutic areas – women's health, urology, pediatrics, and the newly launched dermatology team.  For each of these areas, Alamo will assist with support that includes:

  • Recruiting, training, and assisting the personnel on the Mission sales teams
  • Providing all HR support, performance management, and talent management functions for the sales organization
  • Providing fleet management, expense management, analytics, and sales force automation services through partner organizations
  • Supporting full commercial promotion channels for health care professionals, specifically in Mission's four core therapeutic areas

"We are keenly focused on how Alamo can offer value and provide added benefits through Mission's strategic business partnerships with other pharmaceutical companies servicing similar therapeutic areas," notes Terry Herring, president of Alamo Pharma Services.  "These types of alliances are critically important to us and Alamo will work to both establish and enhance them moving forward.  Further, as this new subsidiary matures, the opportunity exists for us to fine tune this business unit and offer it to clients on a much broader scale, further enhancing Mission's overall diversification strategy."

Joining Herring to run Alamo will be chief operating officer Peter Marchesini.  "Our first priority is to provide operational excellence to the Mission Pharmacal teams," says Marchesini.  "By building and enhancing internal capabilities and leaning on the rich service offerings of key partner organizations, we are able to support our sales teams at the highest levels in the industry."

This developing network of support allows Mission to continually explore unique product and company alliances that further enhance a solid backbone of services.  "Alamo Pharma Services takes advantage of our many years of experience on both the pharma and services sides of the business," adds Herring.  "Providing excellent support for our teams and creating partnering opportunities with both start-up and smaller pharmaceutical companies are two primary drivers of starting Alamo.  With this business in place, we are better positioned to achieve those goals."

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 65 years, the company has been committed to meeting the unique healthcare needs of women throughout all stages of life, pediatric patients, and those persons dealing with urologic and dermatologic conditions.  The company has a proven track record of identifying unmet healthcare needs and developing both innovative prescription and over-the-counter products to meet these needs.  Using only the purest ingredients, Mission Pharmacal provides physicians and consumers with the highest quality pharmaceutical and dietary supplement products on the market today.  Mission Pharmacal is a proud national supporter of the March of Dimes Foundation, whose mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality.  For more information about the company, visit www.missionpharmacal.com.

To contact Alamo Pharma Services:   NewBusiness@alamopharmaservices.com.


'/>"/>
SOURCE Mission Pharmacal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Indevus Announces Submission of New Drug Application
2. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
3. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. Game Commission Announces EHD Confirmed in Fayette County
6. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
7. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
8. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
9. Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission
10. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
11. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12. Februar 2016  Sequent Medical, Inc. gab ... Patienten für eine Studie zur Sicherheit und Wirksamkeit ... für die Behandlung von rupturierten intrakraniellen Aneurysmen begonnen ... der Neuroradiologie an der Universitätsklinik Bicètre in ... CLARYS-Studie hat den ersten Patienten aufgenommen. ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, ... Inc. today announced they will form a partnership ... precision medicine in cancer. The goal of the ... technology with Macrogen,s high-throughput Next Generation Sequencing capabilities ... Clinical Laboratory Improvement Amendments (CLIA) of 1988 by ...
(Date:2/12/2016)... 12 februari 2016 AAIPharma Services ... leverancier van productie en ontwikkeling op maat ... vandaag een uitbreiding aan van steriele vul- ... in Charleston, SC . ... meerdere recente investeringen. http://photos.prnewswire.com/prnh/20150806/256637LOGO ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 , ... ... Cancer Care.” , The print component of “Revolutionizing Cancer Care” is ... New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 copies ...
(Date:2/12/2016)... ... February 12, 2016 , ... US Sport Camps is pleased to announce ... located in Norwalk, serves as the host site and directing the camps is PGA ... have had successful camps in recent years around Des Moines and are fortunate to ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... explosive growth in the field of long term care. With that, says Patrick ... well-trained healthcare professionals in administrative roles in long term care environments. His company, ...
(Date:2/12/2016)... ... ... of restorative dentistry, to date there has been no other option in the U.S. to ... is a now a new protocol in stopping cavity progression; Silver Diamine Fluoride (SDF). ... The application is as simple as drying the tooth and applying the SDF to ...
(Date:2/11/2016)... CA (PRWEB) , ... February 11, 2016 , ... According ... System, a product marketed as a weight loss dietary supplement, is being recalled due ... group Beverly Hills Physicians, because there is not a single supplement on the market ...
Breaking Medicine News(10 mins):